These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 24892704)

  • 21. A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy.
    Kalantari S; Nafar M
    Biomark Med; 2017 Sep; 11(9):781-797. PubMed ID: 28891307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational Aspects of Primary Membranous Nephropathy.
    Hoxha E; Stahl RAK
    Semin Nephrol; 2017 Sep; 37(5):436-446. PubMed ID: 28863791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and monitoring PLA
    Burbelo PD; Beck LH; Waldman M
    J Immunol Methods; 2017 May; 444():17-23. PubMed ID: 28167276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is primary membranous nephropathy a complement mediated disease?
    Reinhard L; Stahl RAK; Hoxha E
    Mol Immunol; 2020 Dec; 128():195-204. PubMed ID: 33142137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.
    Beck LH; Bonegio RG; Lambeau G; Beck DM; Powell DW; Cummins TD; Klein JB; Salant DJ
    N Engl J Med; 2009 Jul; 361(1):11-21. PubMed ID: 19571279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Wang C; Lu H; Yang C; Luo Y
    Chin Med J (Engl); 2014; 127(10):1960-3. PubMed ID: 24824263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiopathic membranous nephropathy: an autoimmune disease.
    Makker SP; Tramontano A
    Semin Nephrol; 2011 Jul; 31(4):333-40. PubMed ID: 21839366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
    Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
    Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prevalence, Characteristics, and Putative Mechanisms of Dual Antigen-Positive Membranous Nephropathy: The Underestimated Condition.
    Uchida T; Oda T
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
    Dahan K
    Rev Med Interne; 2016 Oct; 37(10):674-679. PubMed ID: 27236434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy.
    Xie Q; Li Y; Xue J; Xiong Z; Wang L; Sun Z; Ren Y; Zhu X; Hao CM
    Am J Nephrol; 2015; 41(4-5):345-53. PubMed ID: 26087695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA; McRae JL; Dwyer KM
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
    Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
    BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
    von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
    Front Immunol; 2018; 9():3035. PubMed ID: 30619370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.
    Ronco P; Debiec H
    Lancet; 2015 May; 385(9981):1983-92. PubMed ID: 26090644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery.
    van de Logt AE; Fresquet M; Wetzels JF; Brenchley P
    Kidney Int; 2019 Dec; 96(6):1292-1302. PubMed ID: 31611068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of the CTLD7 domain of human M-type phospholipase A2 receptor.
    Yu B; Hu Z; Kong D; Cheng C; He Y
    J Struct Biol; 2019 Sep; 207(3):295-300. PubMed ID: 31271865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
    Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
    Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
    J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-phospholipase A2 receptor antibody in membranous nephropathy.
    Qin W; Beck LH; Zeng C; Chen Z; Li S; Zuo K; Salant DJ; Liu Z
    J Am Soc Nephrol; 2011 Jun; 22(6):1137-43. PubMed ID: 21566055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.